XML 105 R86.htm IDEA: XBRL DOCUMENT v3.25.0.1
Commitments and Contingencies (Details) - USD ($)
$ in Thousands
3 Months Ended
Jan. 03, 2022
Jun. 30, 2024
Nov. 07, 2022
Feb. 02, 2022
Other Commitments [Line Items]        
Proceeds from litigation settlement   $ 1,000    
Melinta Therapeutics, LLC and Targanta Therapeutics Corporation | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement        
Other Commitments [Line Items]        
Sales milestone payments, receivable     $ 1,000  
Melinta Therapeutics, LLC and Targanta Therapeutics Corporation | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement | Within 30 Days Of First sNDA Filing        
Other Commitments [Line Items]        
Sales milestone payments, receivable       $ 500
Melinta Therapeutics, LLC and Targanta Therapeutics Corporation | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement | Following Approval Of First sNDA        
Other Commitments [Line Items]        
Sales milestone payments, receivable       $ 500
U.S. Product Asset Rights - Sancuso        
Other Commitments [Line Items]        
Tiered royalty payments, threshold $ 3,500      
Tiered royalty payments term (in years) 10 years      
U.S. Product Asset Rights - Sancuso | Maximum        
Other Commitments [Line Items]        
Tiered royalty payments (percentage) 10.00%      
U.S. Product Asset Rights - Sancuso | Minimum        
Other Commitments [Line Items]        
Tiered royalty payments (percentage) 5.00%